Clinical Trial Update: Surgery and BCG in Treating Patients With Bladder Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial conducted by EORTC evaluated surgery plus Bacillus Calmette-Guérin (BCG) for bladder cancer and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• BCG (Bacillus Calmette-Guérin) (Bacillus Calmette-Guérin)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Bladder Cancer | Phase 3 | Status: COMPLETED